Houston, TX, United States of America

Tanner Monroe

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Baylor College of Medicine. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tanner Monroe: Innovator in Cardiomyocyte Renewal

Introduction

Tanner Monroe is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of regenerative medicine, particularly in the area of cardiomyocyte renewal. With a total of 2 patents, his work focuses on innovative methods for generating new heart cells from existing ones.

Latest Patents

Monroe's latest patents include groundbreaking methods for utilizing mutated variants of Yap to induce chromatin accessibility and promote cardiomyocyte renewal. These patents detail techniques for treating existing cardiomyocytes with specific mutated variants of Yap, which encourage these cells to divide and generate new cardiomyocytes. Notably, the mutated variants may include serine-to-alanine substitutions at various positions, enhancing the potential for cell regeneration.

Career Highlights

Tanner Monroe is affiliated with the Baylor College of Medicine, where he conducts his research and development. His work has garnered attention for its potential applications in treating heart diseases and improving cardiac function. Monroe's innovative approaches are paving the way for new therapies in regenerative medicine.

Collaborations

Monroe collaborates with esteemed colleagues such as John M. Leach and James F. Martin. Their combined expertise contributes to the advancement of research in cardiomyocyte renewal and regenerative therapies.

Conclusion

Tanner Monroe's contributions to the field of regenerative medicine are noteworthy, particularly his innovative methods for cardiomyocyte renewal. His work holds promise for future advancements in heart disease treatment and cellular regeneration.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…